Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Jordan S. Orange"'
Autor:
Deepti R, Deshpande, Yesim Y, Demirdag, Rebecca A, Marsh, Kathleen E, Sullivan, Jordan S, Orange
Publikováno v:
Journal of clinical immunology. 41(1)
DiGeorge syndrome has substantial heterogeneity with variable immune deficiency and dysregulation. Implicated immunopathology includes reduced thymic output and increased peripheral homeostatic proliferation with Th2 skewing and expansion of self-rea
Autor:
Caridad Martinez, Robert A. Krance, Nicholas L. Rider, Bilal Omer, Alexander Ngwube, William Shearer, Ghadir Sasa, Nabil Ahmed, Swati Naik, Stephen Gottschalk, Jordan S. Orange, Malcolm K. Brenner, Filiz O. Seeborg, Meng Fen Wu, Carl E. Allen, I. Celine Hanson, Helen E. Heslop, Lenora M. Noroski, Lisa R. Forbes, Sarah K. Nicholas, Hao Liu, Kathryn Leung, Meenakshi Hegde
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:537-541
Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder characterized by a triad of immunodeficiency, eczema, and thrombocytopenia. Currently, hematopoietic stem cell transplantation (HSCT) is the most reliable curative treatment with excellent re
Autor:
Joud Hajjar, Carleigh Kutac, Jordan S. Orange, James J. Dunn, Aba Al-Kaabi, William T. Shearer
Publikováno v:
Journal of Allergy and Clinical Immunology. 142:1358-1360
Autor:
Ifigeneia Tzannou, Premal Lulla, Ann M. Leen, Caridad Martinez, Annette A. Machado, Pedro A. Piedra, Sarah K. Nicholas, Paibel Aguayo-Hiraldo, Jordan S. Orange, Anisha Misra, Juan F. Vera
Publikováno v:
The Journal of Infectious Diseases
Human metapneumovirus (hMPV) is a respiratory virus detected in ≥9% of allogeneic hematopoietic stem cell transplant (HSCT) recipients, in whom it can cause significant morbidity and mortality. Given the lack of effective antivirals, we investigate
Autor:
Jordan S. Orange, Joud Hajjar, Christopher Scalchunes, Filiz O. Seeborg, Carleigh Kutac, Marcia Boyle, Nicholas L. Rider
Publikováno v:
Journal of Clinical Immunology
Purpose Common variable immunodeficiency disorder (CVID) is a primary immunodeficiency disease (PIDD) often associated with severe and chronic infections. Patients commonly receive immunoglobulin (Ig) treatment to reduce the cycle of recurrent infect
Publikováno v:
Journal of Clinical Immunology. 37:153-165
Patients with primary immunodeficiency (PID) often report fatigue, yet this symptom has not been studied in PID. Fatigue affects 6–7.5% of healthy adults. The goal of this study is to estimate the prevalence of fatigue in patients with PID and inve
Autor:
Joud Hajjar, An L, Nguyen, Gregory, Constantine, Carleigh, Kutac, Maha N, Syed, Jordan S, Orange, Kathleen E, Sullivan
Publikováno v:
Journal of clinical immunology. 40(1)
Prophylactic antibiotics (PA) and immunoglobulin replacement (IGRT) are commonly used in specific antibody deficiency (SAD); however, optimal treatment is not well-established. Our purpose is to compare treatment outcomes with IGRT and/or PA among SA
Autor:
Mansour, Alfayez, Sa A, Wang, Sarah A, Bannon, Dimitrios P, Kontoyiannis, Steven M, Kornblau, Jordan S, Orange, Emily M, Mace, Courtney D, DiNardo
Publikováno v:
Leukemialymphoma. 60(8)
Germline mutations in
Autor:
Joud Hajjar, Christopher Scalchunes, Nicholas L. Rider, Jordan S. Orange, Carleigh Kutac, Filiz O. Seeborg
Summary Patients with common variable immunodeficiency (CVID) have increased fatigue compared with the general population. Fatigue is associated with lower quality of life (QoL), which is associated with higher mortality in CVID. This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdd42f59318f6bc913555407a8aa875
https://europepmc.org/articles/PMC6231022/
https://europepmc.org/articles/PMC6231022/
Autor:
Jordan S. Orange, Troy R. Torgerson, Ellen D. Renner, Carolin E. Krätz, Stacey Rylaarsdam, Hans D. Ochs, Gundula Notheis, Beate Hagl, Anne Durandy
Publikováno v:
Clinical Immunology. 222:108638
To assess how B cell phenotype analysis correlates with antigen responses in patients with class switch recombination defects (CSRD) we quantified memory B cells by flow-cytometry and immunized CSRD patients with the neoantigen bacteriophage phiX174